James Peyer — SPARQNOW

At-a-Glance

CEO of Cambrian Bio, focused on developing therapeutics targeting the biological drivers of aging.
Founded Cambrian Bio to translate laboratory breakthroughs in healthy lifespan extension into the clinic.
Started Apollo Ventures, the first company builder in Longevity Therapeutics, where he was a founder, investor, and CEO of multiple companies.
Cofounder and Chairman of the Board at Rapalogix Health and Director & Cofounder of the Longevity Biotechnology Association.
Holds a PhD with a focus on blood stem cell biology from UT Southwestern, as a National Science Foundation Fellow.

Biography

James Peyer is the Founder and CEO of Cambrian Bio, a Distributed Drug Development Company (DisCo) dedicated to creating the next generation of preventative medicines. At Cambrian Bio, he focuses on developing therapeutics that target the biological drivers of aging, aiming to translate laboratory breakthroughs in extending healthy lifespan into clinical applications. He founded the company with the vision of shifting the relationship with medicines from reactive to proactive.